glutamic acid has been researched along with 4-(5-(4-bromophenyl)-3-(6-methyl-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-4,5-dihydro-1h-pyrazol-1-yl)-4-oxobutanoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acker, TM; Burger, PB; Hansen, KB; Jensen, HS; Liotta, DC; Mullasseril, P; Ogden, KK; Snyder, JP; Traynelis, SF; Vance, KM; Yuan, H | 1 |
1 other study(ies) available for glutamic acid and 4-(5-(4-bromophenyl)-3-(6-methyl-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-4,5-dihydro-1h-pyrazol-1-yl)-4-oxobutanoic acid
| Article | Year |
|---|---|
Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators.
Topics: Animals; Cells, Cultured; Cricetinae; DNA, Complementary; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Patch-Clamp Techniques; Pyrazoles; Quinolones; Rats; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2011 |